Sort of like waiting for Christmas with this EU decision. Questions is, is it built into price already or does the approval bring in some institutional investors who may have turned their back on SUPG because of past promises and history.
I would say no. Price is near premerger. Merger was of equals. I think approval might bring mote institutional investors. Progress in pipeline would help. Still waiting almost 2 years to see some of that 2 billion in milestone payments.
You understand the difference between milestone payments and royalty payments right? They never claimed 2 billion in MILESTONE payments. Oh, and BTW, they got a MILESTONE payment in July for $5.4M on the FGFR Kinase inhibitor.